vs
Side-by-side financial comparison of ROCKWELL MEDICAL, INC. (RMTI) and Americas Gold & Silver Corp (USAS). Click either name above to swap in a different company.
Americas Gold & Silver Corp is the larger business by last-quarter revenue ($19.1M vs $17.3M, roughly 1.1× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -9.2% vs -82.3%, a 73.1% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-8.5% vs -28.0%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.
RMTI vs USAS — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $19.1M |
| Net Profit | $-1.6M | $-15.7M |
| Gross Margin | 16.8% | 34.2% |
| Operating Margin | — | — |
| Net Margin | -9.2% | -82.3% |
| Revenue YoY | -8.5% | -28.0% |
| Net Profit YoY | — | 2.8% |
| EPS (diluted) | $-0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $17.3M | — | ||
| Q4 25 | $18.3M | — | ||
| Q3 25 | $15.9M | $19.1M | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $28.3M | $26.5M | ||
| Q2 24 | $25.8M | — |
| Q1 26 | $-1.6M | — | ||
| Q4 25 | $-554.0K | — | ||
| Q3 25 | $-1.8M | $-15.7M | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-756.0K | — | ||
| Q3 24 | $1.7M | $-16.2M | ||
| Q2 24 | $343.0K | — |
| Q1 26 | 16.8% | — | ||
| Q4 25 | 21.1% | — | ||
| Q3 25 | 14.3% | 34.2% | ||
| Q2 25 | 15.6% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 22.0% | 23.6% | ||
| Q2 24 | 17.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -2.2% | — | ||
| Q3 25 | -9.9% | — | ||
| Q2 25 | -8.4% | — | ||
| Q1 25 | -7.2% | — | ||
| Q4 24 | -2.1% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 2.0% | — |
| Q1 26 | -9.2% | — | ||
| Q4 25 | -3.0% | — | ||
| Q3 25 | -11.0% | -82.3% | ||
| Q2 25 | -9.3% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -3.1% | — | ||
| Q3 24 | 5.9% | -60.9% | ||
| Q2 24 | 1.3% | — |
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.04 | — | ||
| Q2 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $39.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.9M | $50.2M |
| Total Assets | $57.4M | $234.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.7M | — | ||
| Q3 25 | $13.6M | $39.1M | ||
| Q2 25 | $12.5M | — | ||
| Q1 25 | $11.4M | — | ||
| Q4 24 | $15.7M | — | ||
| Q3 24 | $12.3M | — | ||
| Q2 24 | $11.9M | — |
| Q1 26 | $35.9M | — | ||
| Q4 25 | $37.0M | — | ||
| Q3 25 | $37.0M | $50.2M | ||
| Q2 25 | $30.4M | — | ||
| Q1 25 | $31.5M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $29.1M | $53.1M | ||
| Q2 24 | $23.5M | — |
| Q1 26 | $57.4M | — | ||
| Q4 25 | $57.1M | — | ||
| Q3 25 | $57.5M | $234.7M | ||
| Q2 25 | $52.6M | — | ||
| Q1 25 | $54.0M | — | ||
| Q4 24 | $59.2M | — | ||
| Q3 24 | $57.1M | — | ||
| Q2 24 | $53.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-12.5M |
| Free Cash FlowOCF − Capex | — | $-41.3M |
| FCF MarginFCF / Revenue | — | -216.5% |
| Capex IntensityCapex / Revenue | — | 150.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.3M | — | ||
| Q3 25 | $-1.3M | $-12.5M | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $865.0K | — | ||
| Q3 24 | $4.3M | $2.4M | ||
| Q2 24 | $1.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.2M | — | ||
| Q3 25 | $-1.5M | $-41.3M | ||
| Q2 25 | $1.7M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $470.0K | — | ||
| Q3 24 | $4.1M | $-11.2M | ||
| Q2 24 | $1.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 12.0% | — | ||
| Q3 25 | -9.6% | -216.5% | ||
| Q2 25 | 10.5% | — | ||
| Q1 25 | -18.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 14.4% | -42.2% | ||
| Q2 24 | 4.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.4% | 150.8% | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.7% | 51.2% | ||
| Q2 24 | 1.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 4.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
